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Although all T lymphocytes express antigen-specific receptors, there is increas-
ingevidence that a population ofblood Tcellsare "naive"inthat theyrespondpoorly
to recall antigens, while other blood T lymphocytes are "memory" cells in that they
proliferate readilyin response to recall antigens, function efficiently asimmuneeffector
cells, and express surface molecules involved in antigen presentation and adhesion
to endothelial cells and extracellular matrix components (1-5). The populations of
"naive" and "memory" T cells are defined by the expression of the family ofCD45
leukocyte common antigens coded by a single 130 kb, 33 exon gene (6). The CD45
gene uses differential splicing to generate multiple mRNA transcripts that direct
the synthesis of 220, 205, 200, 190, and 180 kD glycoproteins (7-12) . While the
220 and 205 kD glycoproteins are expressed on the surface of"naive" T cells and
are detected by the 2144 mAb, the 180 kD glycoprotein is expressedonly on "mem-
ory" T cells and is detected by the UCHL1 antibody (11-14). Relative to the 33
exon CD45 gene, the mRNA transcript coding for the 220 kD 2144+ protein con-
tains the sequence information ofall 33 exons, while the transcript coding for the
205 kD 2144+ protein is missing residues coded by exon VI (12, 13). In contrast,
the CD45 mRNA transcript coding for the 180 kD UCHL1+ protein is missing
exons IV, V, and VI (12-14).
A number ofobservations about T cells at sites ofchronic inflammation suggest
that the relative proportions of"naive" and "memory" T cell populations can vary
within the body. In this regard, while bloodTcells includeboth "naive" and "mem-
ory" T cells in approximately equal proportions, T cells participating in chronic
inflammatory diseases in tissues aremostly comprised of"memory" Tcells (15-18).
The most likely explanation for the apparent compartmentalization of "naive" and
"memory" T cells between tissues and blood is that the "memory" cells accumulate
in inflamed tissues by selective margination, migration and/or proliferation in re-
sponse to antigens at these sites (19, 20). If this is true, the same should hold in
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normal tissues chronically exposed to antigens, i .e ., T cells present in such tissues
should be biased toward relatively more "memory" cells than present in blood .
The present study was directed toward evaluating the relative proportions of "na-
ive" and "memory" T cells on the epithelial surface of the normal lower respiratory
tract, a site constantly exposed to environmental antigens (21). With the knowledge
that "memory" T cells accumulate in areas of chronic inflammation (15-19), we hy-
pothesized that the population of T cells on the epithelial surface of the normal lung
should be dominated by "memory" T cells. As a control, the observations in normal
lung were compared with the T cell populations on the epithelial surface ofthe lower
respiratory tract in chronic beryllium disease, a chronic T cell-mediated inflamma-
tory lung disease caused by an exaggerated response to a specific antigen, beryllium
(22-24). Evaluation of 2H4+ and UCHL1+ surface antigen expression by flow cy-
tometry, together with quantitative analysis of specific forms of CD45 mRNA tran-
scripts, demonstrates that the T cell populations on the epithelial surface ofthe lung
in both groups of individuals are dominated by T lymphocytes expressing the UCHL1
surface glycoprotein and containing CD45 mRNA transcripts missing exons IV,
V, and VI. Thus, the T cells on both normal and chronically inflamed lung epithe-
lial surface are dominated by "memory" type cells.
Materials and Methods
The study population included 10 normal nonsmokers (age 32 ± 3 yr); all had normal
chest x rays, and pulmonary function, and none had history ofpulmonary disease. The pop-
ulation of individuals with chronic beryllium disease included 8 individuals (6 nonsmokers
and 2 smokers; age 39 ± 3 yr), in whom the diagnosis was established using standard criteria
(22-24). None of the patients were taking any medications at the time ofevaluation. All data
are presented as mean ± SEM, and all statistical comparisons were made using the two-
tailed Student's t-test or the paired t-test, as appropriate. Logarithmic transformation was
used to reduce the inequality of variance (25).
Source of TLymphocytes.
￿
Blood mononuclear cells were obtained by venipuncture, and lung
mononuclear cells were obtained by bronchoalveolar lavage (26). The volume of bronchoal-
veolar lavage fluid recovered in the normals was 57 ± 2° of that infused and 59 ± 2%
in individuals with chronic beryllium disease. The amount of epithelial lining fluid (ELF)'
recovered was quantified by the urea method (27). For the normals, 25 ± 3 x 10' cells/Al
ELF were recovered, including 78 t 6% alveolar macrophages, 17 ± 4% lymphocytes, 1 t
lofo neutrophils, and 0% eosinophils. For the individuals with chronic beryllium disease, the
total recovery was 53 ± 25 x 10'/ul ELF, including 34 t 5% alveolar macrophages, 66 ±
6% lymphocytes, 1 ± 1% neutrophils and I ± 1% eosinophils. Blood and lung T cells were
purified using nylon wool columns (28) ; the resulting purity as assessed by the pan T cell
antibody Leu5 (CD2 ; Becton Dickinson & Co., Mountain View, CA) was always >85% (see
below for details of analysis). T cell subsets were purified by FAGS (see below).
Immunofluorescence, Flow Cytometry, and Cell Sorting.
￿
The phenotype of lung and blood T
cells was determined by immunofluorescence and flow cytometry (FAGS IV; Becton Dickin-
son & Co.) as previously described (28) using the unconjugated, FITC- or phycoerythrin
(PE)-conjugated mAbs Leu4 (CD3, T cells; Becton Dickinson & Co.), Leu5 (CD2, T cells;
Becton Dickinson & Co.), Leu3 (CD4, helper/inducer T cells; Becton Dickinson & Co.), Leu2
(CD8, suppressor/cytotoxic T cells; Becton Dickinson & Co.), 2H4 (detecting the CD45 205,
220 kD proteins [12, 29, 30]; Coulter Immunology, Hialeah, FL), UCHLI (detecting the
CD45 180 kD protein [12, 14); Dako Corp., Santa Barbara, CA). Isotype-matched unconju-
' Abbreviations used in this paper: ELF, epithelial lining fluid; PCR, polymerase chain reaction; PE,
phycoerythrin; RT, reverse transcriptase.SALTINI ET AL.
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gated, FITC- or PE-conjugated IgG (Becton Dickinson & Co.) were used as controls. To
determinetheproportions oflung and bloodTcellsexpressing CD45 205, 220 kD andCD45
180 kD surface proteins, T cells were double stained with Leu4-PE and 2H4 or UCHLI
in conjunction with aFITC-conjugated goat anti-mouse antibody (Becton Dickinson& Co.)
and analyzed with theFACS IV as previously described(28). Distributionsof2H4and UCHLI
fluorescence intensity on blood CD3' T cells were analyzed on FACS fluorescence histograms
usinga curve-fittingprogram (COTFIT; B. Murphy, Carnegie-Mellon University, Pittsburgh,
PA) to determine the lower confidence limit (mean t 2 SD) of the 2H4` or UCHLI' peaks;
using this parameter, the percentages of "bright" 2H4' (cells with a specific fluorescence in-
tensity higher than the lower confidence limit) and bright UCHLI` T cells were quantified
in blood and lung.
Blood T cell subsets were purified by FACS into CD2'2H4' T cells and CD2'2H4- T
cell populations using theFACS IV as previously described(28). The purity of the resulting
T cell populations was assessed by analysis of an aliquot of the sorted cells (2H4' cells: >99,70
Leu5', and >98% 2H4' ; 2H4' T cells: >99% Leu5', and <1% 2H4').
Polymerase Chain Reaction (PCR) Amplification and Southern Analysis of CD45 mRNA Tran-
scripts. Thevarious species ofCD45 mRNA transcripts in blood andlung Tcells generated
by alternate splicing of the primary transcription product of the CD45 gene were evaluated
by obtaining mRNA from purified Tcells and T cell subpopulations, converting the mRNA
to cDNA with reversetranscriptase (RT), and then amplifying thespecific cDNAs usingPCR
(31, 32) andCD45-specific oligonucleotide primers. To accomplish this, RNA was extracted
from the T cells using guanidine isothiocyanate cell lysis and purified by cesium chloride
gradient centrifugation (33). When the number of cells was limited to 106, RNA was ex-
tracted by NP40 cell lysis in the presence of ribonuclease inhibitor (RNAsin, 0.2 U/Ftl; Pro-
mega Biotec, Madison, WI)followed by enzymatic digestion ofcontaminatingDNA(DNAse
5 U/ml; RQl PromegaBiotec) and phenol/chloroform extraction in thepresence of 150Ag/ml
carrier tRNA (Bethesda Research Laboratories, Gaithersburg, MD) (34).
To convert Tcell mRNA into cDNA, single-stranded DNA complementary to CD45 ex-
ons I through Xwassynthesized by primer extensionusingaCD45 exon X-specific oligonu-
cleotide primer ("CD45 X,"5' ATGTAACTGAAACTTTTC 3; see Fig. 1) andAMV reverse
transcriptase (Boehringer Mannheim Biochemicals, Indianapolis, IN) in 20 t,l ofRT buffer
(50mM Tris pH 8.3, 8mM MgCI, 30 mM KCI, 0.3 mM dithiothreitol). All oligonucleotides
were synthesized usingan automatedDNAsynthesizer (Applied Biosystems, Inc., Foster City,
CA) according to protocols supplied by the manufacturer and purified using Sephadex G
25 chromatography (PD10; Pharmacia Fine Chemicals, Piscataway, NJ). To amplify CD45-
specific derived cDNAs, primers were used that would amplify all cDNA fragments derived
from the differentially spliced CD45 mRNA transcripts. These CD45-specific primers in-
cluded the 5' primer "CD45 11" that annealed to exon II (5' ATGTATTTGTGGCTTAA-
ACTCTTG 3') and the 3' primer "CD45 IX" that annealed to exon IX (5' GCAGTACAT
GAATTATGAGATATGG 3; seeFig. 1 forlocation ofprimers). Because allCD45 transcripts
are amplified by these primers, DNA products of variable size (376-870 bp) representing
all differentCD45 mRNA species should be obtained (Fig. 1). Since allTcells expressCD45
gene products (1-5), this strategy allowed amplification of all CD45 mRNA species from all
Tcells, permitting quantitative evaluation oftheexpression ofexon IV-positive CD45 mRNA
(CD45R-IV/2H4') and exon IV, V, VI-negative CD45 mRNA (CD45R-0/UCHLI') tran-
scripts using probes specific for each set of transcripts.
To accomplish this, PCRwas performed usingTaq polymerase (GeneAmp; CetusCorp.,
Emeryville, CA) in combination with theCD45-specific primers (2.5 AM each) under stan-
dard conditions using the Thermal cycler (Perkin Elmer-Cetus) for 10 cycles (35). A fixed
aliquot (5%) of the PCR product was then further amplified for 30 cycles. Eight different
CD45 mRNA species are generated by the alternate splicing of the primary gene transcript
(6-13). In order to identify the three PCRamplified DNA fragments corresponding to the
mRNAs coding for the 2H4' and the UCHL-1' proteins, the PCR products were evalu-
ated by Southern blotting analysis using a panel of four exon-specific genomic probes and
exon-exon junction-specific synthetic oligonucleotide probes. The PCR products (10% of
the reaction medium) were size fractionated on 2.5% agarose gels (1.5% NuSieve agarose1126
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Schematic of the CD45 gene showing details of the PCR analysis used to evaluate
the types of CD45 mRNA transcripts in blood and lung T cells. The CD45 gene contains 33
exons(6). Shown arethe5' region encompassing exonsI-X, andthe 3' exon XXXIII; only exons
IV-VI are involved in alternative splicing (7-11). Below the gene is indicated theCD45-specific
oligonucleotide primer used forcDNA synthesis ("CD45-X" cDNA primer; complementary to
exon X) and the 5' and 3' primersused for PCRamplification(5'primer "CD45I1" and3' primer
"CD45IX;" complementary to exon II and IX, respectively). Below the primersare shown the
expected PCR products amplified from CD45R-IV/2H4' mRNA transcripts (870 and 720 bp)
and CD45R0/UCHLI' mRNA transcripts (370 bp). Shownabove thegene are theDNAprobes
used for Southern analysis of PCR-amplified CD45 mRNA, including the "IIIVII probe" to
detect CD45R-0/UCHLI' mRNA transcripts; "III-IV probe" to detect CD45RIV/2114' tran-
scripts; "IV probe" to detect CD45R-IV/2114' transcripts; and a"IX probe" to detect allCD45
mRNA transcripts.
[Polysciences, Inc., Warrington, PA), 1% agarose, 1x TBE buffer [89 mM Tris-HCl, pH
8.3, 89 mM boric acid, 2 mM EDTA]) and transferred to nylon membranes (Zetaprobe;
Biorad Laboratories, Richmond, CA)using0.4 M NaOH (36) for hybridization with specific
probes. TheCD45-specific probes included (see Fig. 1 forlocation): (a)probe IX, panCD45-
specific exon IX, which is not spliced in any CD45 mRNA species (Eco RI/Hind III frag-
ment of the genomic DNA clone pSP6.LCA.204C; M. Streuli, Dana Farber Cancer Insti-
tute, Boston, MA [ll]); (b) probe IV, a probe encompassing exon IV specifically identifying
CD45 mRNA species comprising exon IV (CD45R IV) coding for the 2114' gene product
(11-13) (Bgl II/Bgl II fragment of the genomic DNA clone pSP6.LCA204A; M. Streuli [ll]);
(c) "probe III-IV;" a probe encompassing thejunction of exons III to IV, and thus CD45R-
IVspecific (a synthetic 18-mer [5' TCCCCCACTGGATTGACT 3'] that is complementary
to the exon III to exon IV junction sequence of the 2114* cDNA clone LCA.6 [11, 13]); and
(d)"probe IIIVII;" aprobe encompassing the exon IIIto exon VIIjunction andthus specific
for the mRNA species generatedby complete splicing of exons IV, V, VI (CD45R0) coding
for the UCHLI' gene product (11) (a synthetic 18-mer [5' TCCCCCACTGATGCCTAC 3]
complementary to exon IIIVII junction sequence of the UCHLI' CD45 cDNA clone
LCA.1 [11, 12]). The genomic probes were labeled with [s2P]CTP(200 ACi/pg DNA) by nick
translation (37). Oligonucleotide probes were end-labeled with ["P]ATP (400 ttCi/FAg DNA)
and T4 polynucleotide kinase (Bethesda Research Laboratories). The probes were purifiedSALTINI ET AL.
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by Sephadex G 25 chromatography (37). Filter hybridizationandautoradiographywere per-
formed using standard methods (36).
To validate theability of these methodsto quantify the levels ofCD45-IVmRNA in blood
and lung T cells, T cell RNA (CD45R-IV') was titrated in 20 Al of RT buffer, converted
to cDNA, and amplified as above using PCR. Quantification was obtained with Southern
analysis using the "probe IV" and laser densitometry.
To furtherevaluate whetherthe normal lung T cell populations are dominated by T cells
expressing the CD45 gene in a fashion consistent with their UCHLl' surface phenotype (see
Results), lung T cells were separated into single cells using the FACS IV equipped with a
single cell deposition device (Becton Dickinson &Co.) (38), with 8.26Am beads (Polybeads;
Polysciences, Inc.) sorted on glass slides as acontrol. Thecells were denatured (95°C, 5 min),
the RNA was converted to cDNA (39), and the various CD45' mRNA transcripts were an-
alyzed using specific primers as described above.
Results
Expression of CD45 Surface Proteins by Normal Blood and Lung Cells.
￿
Evaluation of
cell surface expression ofCD45 proteins by normal blood and lung T cells with the
antibodies 2H4 and UCHL1 demonstrated that UCHLI' "memory" T cells selec-
tively compartmentalize to the epithelial surface of the lower respiratory tract (Figs.
2, 3). While the relative proportions of blood T cells of the "naive" 2H4+ and the
Log fluorescence intensity (arbitrary units)
FIGURE 2.
￿
Flow cytometric analysis of normal blood and lung T cell surface expression of the
220and205kD (antibody2H4) andofthe 180kD (antibody UCHLI) CD45 proteins. Theanal-
ysis for 2H4" cells and UCHLl' cells was carriedout using two-color fluorescence together with
the antibody Leu4 (CD3) to identify Tcells. Shown areexamples of2H4 and UCHLI fluores-
cencehistograms ofT cells in the CD3* gate. Abscissa: log fluorescence intensity. Ordinate: cell
number. (A) 2H4' bloodTcells. (B) 2H4' lung T cells. (C UCHLI* blood T cells. (D)UCHLl'
lung Tcells. In each panel is shown the histogram with a control antibody (CTR); thevertical
arrows indicate theregion chosen to separate positive andnegative cells (see MaterialsandMethods).1128
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FIGURE 3.
￿
Flow cytometric evaluation of the
proportions of CD3' T cells expressing the
CD45 2114' "naive" T cell phenotype or the
CD45 UCHLI' "memory" T cell phenotype in
bloodandlungofnormal individuals. Theanal-
ysis was carriedoutas described in Fig. 2. Data
are presentedas theproportions ofCD3' T cells
(Leu4') that are also 2114' or UCHLI' .
"memory" UCHLI' phenotypes are similar (p > 0.1), the lung T cell population
was dominated by "memory" UCHLl' T cells, in striking excess ofthe 2H4+ T cells
(p < 0.01).
CD45 mRNA Expression by 2H4 and 2H4 Blood T Cell Subpopulations.
￿
To analyze
the expression of the CD45 mRNA forms by different T cell populations, PCR
amplification ofCD45 mRNA was used in conjunction with Southern analysis with
a set of four genomic and oligonucleotide DNA probes that allowed specific
identification ofthe mRNA transcripts coding for the CD45RIV/2114+ CD45 prod-
uct and the CD45R0/UCHL1+ CD45 product (see Fig. 1 for location ofthe probes
and expected sizes ofamplified products). Evaluation ofnormal blood Tcell RNA
with "probe IX;'and exon IX-specificprobe, identified several PCRproducts(rang-
ing in size from 370 to 870bp) correspondingto the varioushuman CD45 mRNAs
(at least five [7, 11]) generated by alternate splicing ofthe primary CD45 gene tran-
script. Among them were identified the CD45RIV mRNA species coding for the
2H4+ proteins (870 and 720 by PCR products) as well as the CD45R0 mRNA spe-
cies coding for the UCHLI' protein (370 by PCR product; Fig. 4, lane 1). "Probe
IV," an exon IV-specific probe identified the CD45RIV mRNAs (870 and 720 by
PCR products) but not the CD45R0' 370 by product (lane 2). "Probe III-IV," an
exon III-IV junction-specific probe, also identified the CD45RIV' 870 and 720
byproducts (lane 3). Incontrast, "probe III-VII'" anexon IIIVIIjunction-specific,
probe identified only the CD45R-0+ 370 by product (lane 4).
To demonstratethat differential T cell CD45 expression in"naive" and"memory"
T cells at the mRNA level correlates with the 2H4+ and UCHLI' surface protein
phenotypes, respectively, CD45RIV' and CD45R0' mRNA levels were evaluated
in purified 2114+ T cells and 2114- purified T cells (Fig. 5). Analysis of purified
normal blood CD3+2114+ T cells (Fig. 5 A) showed that they specifically expressed
CD45RIV mRNA (870 and 720 by products [lane 1]), but no MOM mRNA
transcripts (370 by product [lane 2]). In contrast, CD3+2114- T cells (Fig. 5 B) do
not express CD45R-IV (870 and720by products [lane3]), but didexpress CD45R-0
transcripts (370 by [lane 4]). These observations are consistent with the concept
that the specific CD45 RNA splicing patterns are differentin the "naive" and"mem-SALTINI ET AL .
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FIGURE 4 .
￿
Examples ofSouth-
ern analysis of PCR-amplified
bloodT cellCD45mRNA tran-
scripts, T cell RNA was con-
verted to cDNA, amplified using
5' CD45-II and 3' CD45-IX
primers (see Fig. 1), and ana-
lyzed using "P-labeled probes
as indicated for each lane. (Lane
1) Analysis with the"IXprobe."
The 870 and 720 by products
corresponding to CD45R-IV
mRNAs coding for the 220and
205kD 2H4' proteins, respec-
tively, are indicated, as are the
370by products corresponding
to theCD45R0mRNA coding
for the 180kD UCHL1'CD45
protein. (Lane 2) Analysis with
the "IV probe."The870and720
by CD45R-IV* products are
detected . (Lane 3) Analysis with
the "III-N probe;' showing the
870 and 720 by CD45R-IV'
transcripts. (Lane 4) Analysis
with the "IIIVII probe," indicat-
ing CD45R-0' 370 by tran-
scripts .
ory" T cell populations, and correlate directly with the CD45 220, 205, and the 180
kD surface proteins that identify two nonoverlapping populations ofT cells (1, 5).
Quantitative Evaluation ofCD45 Expression in Normal BloodandLung TCells . The
accuracy of the quantification ofCD45R-IV' mRNA levels byPCR amplification
was evaluated by preparing mixtures ofa fixed amount of lung T cellmRNA (con-
taining very little CD45RIVmRNA) with increasingamountsofbloodT cellmRNA
(containing approximately equal amounts ofCD45R-IV and CD45R-0 mRNA).
Analysis of the amounts of PCRamplified CD45RIV' specific products demon-
strated : (a) the methodology used could accurately quantify the amounts of specific
CD45 mRNA transcript (correlation of input mRNA to specific output mRNA r
= 0.99) ; and (b) the method was very sensitive, with as few as 1% of2H4' T cells
expressing CD45R-IV mRNA detectable (Fig . 6) .
Using this approach,PCR analysis of blood and lungTcell CD45 mRNA levels
using exon IX- and exon IV-specific CD45 probes demonstrated that in contrast
to blood where the two types of CD45 mRNA patterns are equally expressed, T
cells in the normal lung are dominated by T cells expressing the CD45R-0 "mem-
ory"Tcell-typemRNA transcripts(Fig. 7) . Strikingly, while bloodT cells expressed
the CD45RIV/2H4' mRNA transcripts (870 and 720 by CD45RIV+ fragments ;
Fig. 7A, lane 1), very little ofthismRNA was present in lungT cells (lane 2) . Quan-
titative assessment of these transcript levels demonstrated the bloodT cells contained,
on the average, 17-fold more CD45RIVmRNA per cell than did autologous lung
T cells (Fig . 7 A, right; blood 35 t 13 density units, lung 2 ± 1 density units p<
0.01) . In contrast, both blood and lung T cells expressed the CD45R0/UCHLI'1130
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FIGURE 5 .
￿
Examples ofPCR analysis of CD45 mRNA transcripts expressed by purified blood
CD3*2H4* "naive"T cells and CD3*2H4 - "memory" Tcell subpopulations . (A) Left, fluores-
cence histogram of cell sorter purified CD3*2H4* Tcells (solid line) . The profile of the unfrac-
tionated CD3* T cell population is shown as adotted line . Abscissa : 2H4* log fluorescence in-
tensity. Ordinate : cell number. Right, Southern analysis of PCR-amplified mRNA transcripts
from the purified CD3*2H4* Tcells. The probes were s2P-labeled . (Lane 1) Analysis with "III-
IV probe." (Lane 2) Analysis with the "IIIVIIprobe." Indicated are the870and 720 by products
indicative of the CD45R-IV/2H4* transcripts . No 370byCD45R0' product was observed . (B)
Left, fluorescence histogram ofcell sorter-purified CD3*2H4-T cells (solid line). The profile of
the unfractionated CD3* T cell population is shown as a dotted line . Abscissa : 2H4* log fluores-
cence intensity. Ordinate : cell number. Right, Southern analysis ofPCR amplified mRNA tran-
scripts from the purified CD3*2H4-T cells . (Lane 3) Analysis with the "III-IV probe." (Lane
4) Analysis with the "IIIVII probe." Indicated is the 370 by product indicative of CD45R-0/
UCHLI* transcripts . No 870 or 720 by CD45RIV* transcripts were observed .
mRNA transcripts (370 by CD45R-0 product; Fig . 7 B) . Furthermore, the blood
andlung T cells contained similar levels of the CD45R-0* transcripts(blood 13 t 2
density units, lung 14 t 2 density units; p > 0.7 ; Fig . 7 B, right) . As further evi-
dence ofthe nonoverlapping expression ofspecific CD45mRNA transcripts by lung
UCHLI' T cells, single cell analysis of normal lung T cells demonstrated that 23
of 26 lung T cells expressed the CD45R-0* type of transcripts but none expressed
CD45RIV* transcripts (data not shown) .b f
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FIGURE 6.
￿
Quantification of CD45R-IV mRNA using
cDNA synthesis, PCRamplification, Southern analysis with
"probe IV," andlaserdensitometry. Data areshownas den-
sitometryunits. Ordinate: CD45R-IV mRNA levels (den-
sity units). Abscissa: blood Tcell RNA(CD45R-IV*) con-
centrations (/~g/20 Wl of cDNA synthesis medium) added
to a fixed amount (I kg/20 pl) of lung T cell RNA.
Cell Surface andmRNA Analysis ofCD45 Expression by BloodandLung Tcells in Chronic
Beryllium Disease. Evaluation oftheblood and lungT cells in individualswith chronic
beryllium disease for the expression of CD45 isoforms using flow cytometry with
the antibodies 2144 and UCHLI demonstrated that, similarto thenormals, thelung
T cell population was dominated by UCHLl+ "memory" T cells. While blood T
cells from these individuals comprised proportions of"naive" 2144+ and "memory"
UCHLV Tcells that were similar to those observed in normals (2144+ 55 t 4%
ofCD3+, p > 0.5 compared with normal; UCHLl + 40 t 4%, p > 0.05 compared
with 2H4+, p > 0.1 compared with normal), the lung T cells were dominated by
UCHL1+ "memory" T-cells (95 ± 2% ofCD3+; 2144+ 3 ± 1% ofCD3+, p < 0.01
UCHLI+ compared with 2144+).
Consistent with these observations, PCR analysis ofthe levels ofCD45 mRNA
types in the T cells from the same individuals showed that T cells expressing the
CD45R-0/UCHLI + mRNA accumulate in the lung of individuals with chronic
beryllium disease. The lung Tcells contained significantly less CD45RIV mRNA
than blood T cells (blood 35 ± 4 densitometric units [1.2 t 0.3 log transformed
units]; lung 2 ± 1 densitometric units [0.4 ± 0.3 log transformed units]; p < 0.01;
Fig. 8], demonstrating that only a small proportion oflung T cells expressed the
CD45 gene product in its"naive"nonspliced form. In contrast, lungT cells expressed
significant levels ofthe CD45R-0 mRNA coding for the 180 kD UCHLl + protein
(blood 20 ± 4 densitometric units (1.3 ± 0.1 log transformed units); lung 16 f
5 densitometric units (1.1 ± 0.1 log transformed units); p > 0.2; Fig. 8] indicating
that these lung T cells express the CD45R0/UCHL1+ but not the CD45R-IV/2144+
mRNA, i.e., they express the "memory" Tcell phenotype oftheCD45 gene. Finally,
quantification ofthe absolute numbers ofTcells on theepithelial surface ofthelungs
ofnormals and individuals with chronic beryllium disease showed that in the lungs
ofthese patients, chronic antigen-specific inflammation drives the accumulation of
exaggerated numbers of "memory" T cells. In this regard, the concentration of
CD3+ T cells present in the epithelial lining fluid of the lung of individuals with
chronic berylliumdisease was markedly increased (ninefold) compared with normal1132
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FIGURE 7 .
￿
Evaluation ofCD45
mRNA transcripts by normal
blood and lungT cells. (A) Eval-
uation for CD45R-IV/2H4'
mRNA transcripts . On the left
is shown an example ofthe anal-
ysis using PCR and Southern
analysis with a 32P-labeled "IV
probe ." (Lane 1) Blood T cell
RNA . (Lane 2) Lung T cell
RNA . Arrows indicate the
CD45R-IV' 870 and 720 by
products. On the right is shown
the quantification of the relative
amounts ofCD45R-IVmRNA
transcripts in blood and lung T
cells of several normal individ-
uals . The data are shown as ar-
bitrary density units . (B) Eval-
uation for CD45R-0/UCHLl'
mRNA transcripts .On the left
is shown an example ofthe anal-
ysis using PCR and Southern
analysis with a 's2P-labeled "IX
probe." (Lane 3) Blood T cell
RNA . (Lane 4) Lung T cell
RNA . The arrow indicates the
CD45R-0 370 by product . On
the right is shown the quantifi-
cation ofCD45R0 mRNA tran-
scripts in the blood and lung T
cells of several normal individ-
uals . The data are shown as ar-
bitrary density units . In A and
B, each data point represents a
single individual and the lines
indicates the data from the same
individual .
(30.0 ± 14.0 x 103 cells/Al ELF [4 .3 ± 0.2 log transformed concentration] ; nor-
mal 3 .2 ± 0.9 x 103 [3.3 ± 0.1 log transformed concentration] ; p < 0.01; Fig . 9) .
Strikingly, within the lung CD3' T cell population, the total number of "naive"
2H4' T cells in chronic beryllium disease was similar to normal (CD3'2H4', 0.9
± 0.5 x 103 cells/wl ELF [2 .6 t 0.2 log transformed concentration] ; normal 0.2
± 0.2 x 103 [2 .1 ± 0.2 log transformed concentration) ; p > 0.1 ; Fig. 9), but the
number of"memory" UCHL1 ` T cells was markedly increased compared with nor-
mal (CD3'UCHLl', 27.2 ± 12 .1 x 103 cells/Al ELF [4.2 t 0.1 log transformed
concentration] ; normal 2 .9 ± 0.9 x 103 [3.2 t 0.2 log transformed concentration] ;
p< 0.01; Fig. 9), and accounted entirely for the increase in the T cell numbers in
the lower respiratory tract of these individuals . Thus, the T cell populations in an
antigen-driven chronic inflammatory disorder have the same "memory" type char-m
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FIGURE 8.
￿
Evaluation ofCD43 InRNAexpression by bloodand
lung T cells of individuals with chronic beryllium disease. The
analysis was identical to that forthe normal individuals usingthe
"IV probe" (CD45R-IV mRNA transcripts) and "IX probe"
(CD45R-0 mRNA transcripts). Data are shown as arbitraryden-
sity units. Each data point represents asingle individual. Thelines
connect the data from the same individual.
acteristics as it is found in the normal lung, but the inflammatory disease has a mark-
edly increased total number of these cells.
Discussion
All T cells are characterized by their surface expression of the a/f or -Y/S antigen
receptors (40). The role ofthe ,y/S receptor is not fully defined (41), but the TCR-a/0
clearly imparts upon T cells the ability to bind to antigens in the context of major
histocompatibility molecules of class I (cytotoxic T cells) or class II (helper T cells)
(42). While all T cells have the potential to bind to specific antigens (40, 42), it has
become clear that T cells can be classified into two populations that respond to anti-
Chronic Normal Chronic
beryllium beryllium
disease disease
FIGURE 9. Quantification of
the numbersof CD'2H4' "na-
ive" T cells and CD3'UCHL1'
.memory"Tcellson theepithe-
lial surfaceofthelowerrespira-
tory tract ofnormalsand indi-
viduals with chronic beryllium
disease. The analysis was by
flow cytometry with the anti-
bodies Leu4 (CD3), 2H4
(CD45R-IV'), and UCHLI
(CD45R-0') as indicated in'
Fig. 2. Data arepresentedas ab-
solute numbers ofMY, CD3'
2H4', and CD3'UCHLI' T
cells/Al of ELF recovered.1134
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gens differently (1-4, 43). "Naive" T cells donot respondwellto recall antigens (1-4),
but do proliferate to some extent in response to anti-CD3e chain antibodies in the
presence of IL-2 (44) or factors released by CD4+ Tcells (45). In contrast, "mem-
ory" T cells of either the CD4+ and the CD8' subsets respond to recall antigens
(46, 47), proliferate strongly following CD3e stimulation (43), and do not require
exogenous IL-2 (43-45), characteristics ofT cells competent to initiate*immune re-
sponses to recall antigens. Current concepts hold that postthymic T cells with the
"naive" T cells phenotype undergo further differentiation to become "memory" T
cells, a process that entails enhanced expression ofa number of adhesion molecules
such as CD2, LFAI, and CDW29, the loss ofsurface CD45/2H4+ proteins, and the
acquisition ofthe expression of CD45/UCHLI + proteins (1-5, 48, 49). In the con-
text that tissues such as the epithelial surface of the lung are chronically exposed
to a variety of antigens, the present study was directed toward defining the status
oftheTcellpopulations on thepulmonaryepithelial surfacein regardsto their state
of differentiation as "naive" or "memory" T cells, i.e., whether the normal tissue T
cell population at a site chronically exposed to antigens is specialized in responding
to recall antigens, or is as heterogeneous as are blood T cells.
Interestingly, we found that thepopulation ofTcells inthe normal lung are domi-
nated by CD45R-0+, UCHLV "memory" T cells. Furthermore, comparison of T
cell high density expression ofCD45 2114' and UCHLV proteins ("bright" 2114'
and UCHLV cells) with the expression ofspecific CD45 mRNA transcripts showed
that, like the two populations of T cells in the blood, these two populations in the
lung express alternative, nonoverlapping gene programs, i.e., 2114+ T cells do not
express theCD45R0mRNA and viceversa. Theobservations with the normal lung
T cells suggest that the T cells that compartmentalize to and dominate the T cell
populations on the lung epithelial surface are already differentiated, "memory" T
cells. Several lines of evidence support this concept:
(a) Combined flow cytometry and mRNA analysis demonstrated that most lung
2114-UCHLI+ T cells expressed only the spliced CD45R-0 mRNA form, suggest-
ing that theregulatory mechanism that directs tissue-specific splicingofCD45 RNA
(50) hadoccurred previously. Consistent with this concept, single cell CD45 mRNA
analysis oflungT cells showed they expressed CD45R0 andnotCD45RIV mRNA
transcripts.
(b) In vitro studies with blood T cells demonstrated that activation of"naive" T
cells with appropriate stimuli induces progressive loss of surface expression of
2114+CD45 and at the same time induces the expression ofUCHLI +CD45 (48, 49;
and Sanders, M., Clinical Pharmacology, Upjohn Co., Kalamazoo, MI, personal
communication).
(c) Itis unlikely that lung Tcell activation ofthe IL-2 gene andT cellproliferation
drive normal lung T cells to switch from 2H4+ to UCHL1' in situ in the lower re-
spiratory tract, since normal lungTcells are proliferating at very low rates (51) and
are not expressing IL-2 mRNA (51, 52). In addition, consistent with the concept
that lung T cells are alreadydifferentiated, lung T cells express the very late activa-
tion surface antigen VLA1 in much larger proportions than early activation surface
proteins such as the IL-2 receptor (53).
(d) "Memory" Tcells are likely to migrate into the normal lung at a higher rate
than "naive" T cells. In this regard, as a consequence of a higher surface densitySALTINI ET AL.
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ofCD2 and LFA-1 (3, 5, 19), adhesion moleculesthat bind to the LFA3 and ICAM-1
intercellular adhesion ligands (54), "memory" T cells have the increased ability of
adhering to capillary endothelial cells and of negotiating tissues. Furthermore, be-
causenormal alveolar macrophages are capable ofhigh levels of production ofTNFa
(55), a potent cytokine capable of upregulating LFA3 and ICAM1 expression in a
number of cells (56), lung exposure to airborne particles and antigens may contrib-
ute to activate the recruitment of significant numbers of differentiated "memory"
T cells to the lung.
Together, these observations are relevant to the understanding of the normal im-
mune response in the lung, in that they suggest that the lung is a "specialized" site
of T cell response to recall antigens. These "memory" T cells have the potential of
a prompt release of the macrophage-activating lymphokine IFN--y, and a prompt,
significant response to T cell receptor stimulation by recall antigens (5, 43). In the
same context, the data are consistent with the concept that the lung epithelial sur-
face may not be the site ofprimary immune responses. Although lower respiratory
tract immunization can generate cytotoxic and IFN-.y-mediated recall immune re-
sponses (57, 58), this may be secondary to the transport of antigen to lung lymph
nodes by macrophages (59) rather than local T cell stimulation. Furthermore, ex-
periments with local lung Bacillus Calmette-Guerin vaccinations have shown that
local lung immunization may be less efficacious than other vaccination routes (60),
suggesting that T cell activation within the lymph nodes (a tissue that is rich in
2H4+ Tcells [61, 62]) may be necessary for optimal immunization against new an-
tigens.
Further support of the conceptthat "memory" T cells compartmentalize to antigen-
exposed tissues is provided by the observation that the chronic presence of a beryl-
lium burden in thelower respiratory tract of individuals with chronicberyllium dis-
ease dramatically expands the numbers of UCHLI + T cells in the lung, i.e., the
beryllium-specific UCHLI+ T cells, already present or recruited to the lungs, are
stimulated in the local milieu to proliferate. These observations are consistent with
studies with anti-CD45 and CDw29 antibodies, demonstrating that at sitesof chronic
inflammation such as leprosy skin lesions (63), tuberculosis pleural effusions (16),
and rheumatoid joint fluid (15, 17-19), T cells are dominated by 2H4-/UCHL1 +/
4B4+ (CDw29+) T cells. This suggests that chronic exposure to antigens is charac-
terized by the compartmentalization of larger numbers of "memory" type T cells
in tissues (19). The observations in chronic beryllium disease also support the con-
cept that immune response of this disease is a normal, albeit an exaggeratedresponse,
i.e., the exaggerated immune process results from a normal, although heightened
response of compartmentalized antigen-specific "memory" T cells.
In conclusion, this study demonstrates that in the lung, a model of normal tissue
chronically exposed to antigens, the local T cell population is dominated by "mem-
ory" 2H4- UCHLI` T cells. The observation is important to the understanding
oftissue-lung immunity in twoways. First, it puts theconcept of postthymic differen-
tiation of "memory" T cells (1-5, 48, 49) in the context of the role of T cell popula-
tions in tissue immune responses(64, 65). Second, by supporting and further defining
the concept of the lung as an immune compartment, it is suggested that strategies
forthe evaluation of the immunoregulatory processes in chronic inflammatory lung
disorders must be centered on evaluating "local" processes since evaluation of the113 6
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blood will not yield a valid picture of the immune processes ongoing within the tis-
sue. Finally, the finding that the normal lung is the site of a specialized population
of T cells has important implications to chronic immune disorders of the lung. In
this regard, in the context of a number of studies demonstrating that the 2H4' "na-
ive" T cell population, but not the population of UCLH1' "memory" T cells, con-
tains T cells capable of inducing suppressor T cells (30), it is possible that persistent
activation of sensitized helper T cells in the lung milieu (such as in individuals with
chronic beryllium disease) may not be accompanied by local generation of a down
regulatory T cell response, with the concomitant suppressor T cell activation (23-
25, 66).
Summary
Expression of alternatively spliced products of the CD45 leukocyte common anti-
gen gene identifies two populations ofblood T cells: "naive" T cells (containing CD45R-
IV mRNA transcripts, CD45 220, 205 kD surface proteins detected with antibody
2H4) that respond poorly to recall antigens, and "memory" T cells (containing
CD45R-0 mRNA transcripts, expressing CD45 180 kD protein, detected with anti-
body UCHLI) that respond promptly to recall antigens. While blood contains ap-
proximately equal numbers of "naive" and "memory" T cells, it is known that
UCHLI' "memory" T cells accumulate at sites of chronic inflammation. To test the
concept that "memory" T cells are a feature ofthe T lymphocyte populations present
in tissues chronically exposed to antigens in normals as well as in individuals with
chronic inflammation, we evaluated T lymphocytes obtained from blood and the
epithelial surface of the lower respiratory tract of normal individuals for the expres-
sion ofspecific CD45 surface protein isoforms and corresponding mRNA transcripts.
Flow cytometric analysis of CD45 220, 205, and 180 kD surface proteins demon-
strated that lung T cells of normals are dominated by UCHLI' "memory" cells (86
± 2%) while autologous blood T cells have equal proportions of "memory"
UCHL1' and "naive" 2H4' T cells. In addition, polymerase chain reaction analy-
sis of CD45 mRNA transcripts revealed that the lung cellsexpressed CD45R0 mRNA
transcripts but 17-fold fewer CD45RIV mRNA transcripts than autologous blood
T cells (,6 < 0.01). The pattern of lung T cells being dominated by CD45R0 mRNA',
UCHLl' "memory" T cells was also observed in individuals with chronic beryllium
disease, an example of a chronic inflammatory disease in which antigen-specific T
cells accumulate on the pulmonary epithelial surface. Like the normals, the lung
T cells of the beryllium disease patients were dominated by CD45R-0 mRNA tran-
script', UCHLI', T cells. However, on a quantitative basis, the beryllium patients
contained far greater numbers of T cells, i.e., the T cell populations on the surface
of the normal and inflamed lung are similar in character ("memory" T cells) but
differ in numbers (there are far more in the chronic inflammatory state). Thus, T
cell populations on the epithelial surface ofthe normal lung likely reflect the chronic
exposure to a diverse set of antigens, with a pattern that is qualitatively similar to
that observed among T cells accumulating in response to a single antigen .
We thank M. Streuli (Dana Farber Cancer Institute, Boston, MA) for the gift of the CD45
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